Key facts
- It has raised $3.5M; the latest was Early Stage VC ($3.5M) in Dec 2024.
- Notable investors include Raga Partners (New York).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Phy
- ·The full record, as it builds
Funding rounds
No funding rounds for Phy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phy
Developer of a body movement tracking platform intended to provide musculoskeletal (MSK) care. The company's platform offers a three-dimensional (3D) view of the human body to understand the chain of musculoskeletal interactions and offers a tailor-made movement plan, enabling users to address their mobility and postural needs easily.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 14
- Website
- phy.health/
- Ownership
- Privately Held (backing)
Phy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phy in its N-PORT filings yet. We sweep new filings monthly.